VANCOUVER, Feb. 13, 2021 (GLOBE NEWSWIRE) – Market Buzz, a trusted digital source in finance, covers the latest in stock market news to help investors stay informed. The Green Wave Update highlights cannabis companies poised for growth. Each weekly rundown provides pertinent information about the ever-evolving cannabis marketplace. This content does not constitute investment advice.
Canopy Animal Health a division of Canopy Growth Corporation (CGC) recently launched SurityPro – its new line of CBD pet-specialty products. Developed by Canopy Animal Health’s leading scientists, the new generation dog products support healthy aging, calm behavior, joint health and flexibility along with their overall physical and mental well-being.
February 4, 2021 – Canopy Animal Health provided further details about its new SurityPro CBD products. Each product is offered in three sizes: Small dogs (5-25 pounds), medium dogs (26-50 pounds) and large dogs (51-130 pounds).
February 11, 2021 – Canopy Animal Health released its comprehensive study, “Preliminary Investigation of the Safety of Escalating Cannabinoid Doses in Healthy Dogs,” available at https://doi.org/10.3389/fvets.2020.00051
Chemesis International Inc. (CADMF) is taking advantage of new technologies to pivot its retail model away from traditional bricks and mortar stores. The company’s infrastructure is set to thrive as it deploys its new AI-enabled VICKI systems to airports, sports venues and shopping malls. CADMF hopes to deploy 5,000 vending units in new markets, if this is accomplished it would increase annual revenue by a projected $250 million.
December 7, 2020 – CADMF announced its partnership with the Reebok Lab in West Hollywood, California. With approval to place its VICKI self-checkout unit in the gym, the company will receive important data points for its successful expansion within the fitness industry. The two companies will develop an educational platform to createproducts that enhance an athlete’s performance.
December 3, 2020 – CADMF announced its brand partnership with Ubican Global as its primary supplier for its US VICKI program. The company is a trusted supplier of a family of more than 10 carefully cultivated brands, each with a diversity of cannabis products. Each brand uses a customized approach to accommodate its demographic, increase brand loyalty and build reoccurring revenue streams.
Tilray Inc (TLRY) provides medical cannabis to patients, physicians, pharmacies, governments, hospitals and researchers in eight countries. The company strives to cultivate and deliver the benefits of medical cannabis safely and reliably.
February 9, 2021 – TLRY announced it has established an agreement with Grow Pharma to import and distribute its medical cannabis products into the United Kingdom (UK), allowing authorized UK patients to access locally-available medical cannabis solutions.
December 16, 2021 – TLRY merged with competitor Aphria Inc. to create a new company using the Tilray name. The two announced a projected pro forma revenue of $874 million as a result of the deal. Since then, the two stocks have traded separately.
Curaleaf Holdings Inc. (CURA) is a leading U.S. provider of cannabis products. The company owns and operates 100 dispensaries, 23 cultivation sites and 30 processing sites. CURA attributes its success to its leadership team and suite of cutting-edge products including Classic Chews, Sublingual Tablets, Live Blends and more.
February 5, 2021 – CURA announced the opening of its 34th dispensary in Florida and 98th dispensary nationwide. St. Petersburg will now have convenient access to two CURA dispensaries, open to patients with a valid Florida Medical Marijuana ID card.
“Since opening our first dispensary in St. Petersburg in 2018, our team has forged invaluable patient connections, and we look forward to offering our world-class care to even more patients through this second location,” said Joe Bayern, CEO of Curaleaf.
Sundial Growers Inc. (SNDL) is a licensed cannabis producer located in Calgary, Alberta. It crafts state-of-the-art indoor facilities for the production of premium cannabis. Using an individualized “room” approach, the Canadian operations cultivate small batch cannabis with 448,000 square feet of total space.
February 4, 2021 – SNDL announced the closing of its $74.5 million registered offering. Following the closing of the offering, the Calgary-based company has unrestricted cash of approximately $610 million, an estimated $61 million in marketable securities and loans and roughly 1.56 billion common shares outstanding.
Green Thumb Industries (GTII) offers a portfolio of recreational marijuana products that are distributed in 11 states. Its products are diverse, including Solomon’s cannabis-infused skin lotions and even dogwalker pre-rolled blunts. GTII currently operates 13 manufacturing facilities and 96 licensed retail locations across 12 states.
February 9, 2021 – GTII announced its first public sale of equity registered with the U.S. Securities Exchange Commission to raise USD $100 million. “Institutional investors are waking up to the great American cannabis growth story,” said Green Thumb Founder and CEO Ben Kovler. “This investment reflects the very real interest, understanding and momentum behind the potential $100 billion U.S. cannabis opportunity that is happening now.
April 12, 2020 – When lots of companies were feeling the pain of the pandemic, GTII managed to grow their total revenue by 16.6% to $119.6 million. This growth momentum only increased as the economy began to reopen.
Trulieve Cannabis Corp. (TRUL) is a medical cannabis company that cultivates and produces products in-house and distributes them in Trulieve branded dispensaries in Florida, California, Massachusetts and Connecticut. It also offers home delivery to patients.
February 10, 2021 – TRUL announced its opening of its new Florida dispensary, making it the company’s 79thnationwide. The retail location will be the company’s third in Jacksonville, giving patients access to the state’s wide offering to high-quality medical cannabis products. “It’s important to us that patients have safe, reliable access to the medications they use every day, and to continue to provide that with our newest Jacksonville dispensary,” said Trulieve CEO Kim Rivers.
February 3, 2021 – TRUL announced the expansion of its Blue River extracts lineup with Cold Cure Live Rosin. This newest addition to the Blue River products sold in Trulieve stores across Florida is its most premium concentrate offering to date. Cold Cure Live Rosin is a solvent free extract offering a balanced experience between flavor, effect and potency with extreme purity.
“We’ve worked closely with the Blue River team over the past several months to perfect this process and we know patients will find powerful, potent relief with Cold Cure Live Rosin,” said Trulieve Chief Marketing Officer Valda Coryat.
About Market Buzz:
Market Buzz is a financial news platform that offers investors premium information on high-growth Potential Stocks, Industry Disruptors, & Capitalizers along with US and Canadian Market Opportunities.www.MarketBuzz.ca. This content does not constitute investment advice.Contact Information: